News for Bioline RX Ltd - Google Finance

BIOLINERX LTD. : BioLineRx Enters into “At-The-Market” Offering Agreement ...

Fri, 17 May 2013 17:04:27 GMT

BIOLINERX LTD. : BioLineRx Enters into “At-The-Market” Offering Agreement ...
4-traders (press release) - May 17, 2013

17, 2013-- BioLineRx Ltd. (NASDAQ: BLRX)(TASE: BLRX), a biopharmaceutical development company, announced today that it has entered into an at-the-market (ATM) sales agency agreement with Stifel.

BioLineRx's BL-7010, for the Treatment of Celiac, to be Presented at Two ...

Thu, 02 May 2013 16:27:57 GMT

BioLineRx's BL-7010, for the Treatment of Celiac, to be Presented at Two ...
Wall Street Journal (press release) - May 2, 2013

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that the Company was invited to deliver an oral presentation at the 2013 National Education Conference & Gluten-Free Expo, the Celiac Disease ...

BioLineRx Reports First Quarter 2013 Results

Wed, 08 May 2013 03:49:46 GMT

BioLineRx Reports First Quarter 2013 Results
DailyFinance - May 8, 2013

BioLineRx Reports First Quarter 2013 Results. JERUSALEM--(BUSINESS WIRE)-- BioLineRx Ltd. (NAS: BLRX) (TASE: BLRX), a biopharmaceutical development company, today reported its results for the quarter ended March 31, 2013.

BioLineRx to Present at the Oppenheimer 14th Annual Israeli Conference on ...

Thu, 09 May 2013 11:01:15 GMT

BioLineRx to Present at the Oppenheimer 14th Annual Israeli Conference on ...
MarketWatch (press release) - May 9, 2013

JERUSALEM, May 09, 2013 (BUSINESS WIRE) -- BioLineRx Ltd. (NASDAQ:BLRX) (tase:BLRX), a biopharmaceutical development company, announced today that its Chief Executive Officer, Kinneret Savitsky, Ph.

BioLineRx To Present At Needham Healthcare Conference ; Webcast At 3:40 ...

Tue, 30 Apr 2013 18:47:46 GMT

BioLineRx To Present At Needham Healthcare Conference ; Webcast At 3:40 ...
NASDAQ - Apr 30, 2013

... 02:43:00 PM EDT. Vote up. loading. (RTTNews.com) - BioLineRx Ltd.( BLRX ) will present at the 12th Annual Needham Healthcare Conference in New York.

BioLineRx (BLRX) Releases Quarterly Earnings Results, Misses Estimates By ...

Tue, 07 May 2013 15:54:23 GMT

BioLineRx (BLRX) Releases Quarterly Earnings Results, Misses Estimates By ...
Mideast Time - May 7, 2013

BioLineRx Ltd. logo BioLineRx (NASDAQ: BLRX) posted its quarterly earnings results on Tuesday. The company reported ($0.20) earnings per share for the quarter, missing the analysts' consensus estimate of ($0.02) by $0.18, Analyst Ratings Network ...

BioLineRx Pipeline Returns To The Winner's Circle

Wed, 01 May 2013 12:43:46 GMT

BioLineRx Pipeline Returns To The Winner's Circle
Seeking Alpha - May 1, 2013

After disappointing investors in March by terminating a Phase 2/3 clinical trial of an anti-psychotic drug candidate for the treatment of schizophrenia, BioLineRx (NASDAQ: BLRX) bounced back in April, posting positive Phase 2a results with an oral ...

This Israeli Orthodox Professor Discovered a Treatment for Alzheimer's – and ...

Sat, 18 May 2013 18:04:30 GMT

This Israeli Orthodox Professor Discovered a Treatment for Alzheimer's – and ...
Jewish Business News - May 18, 2013

The company is run by Dr. Yona Gefen, , former director of product development BioLineRx. Chairman is Ya'acov Michlin, CEO of ... Another Israeli attempt, made by 'Allon Therapeutics Inc.' failed to achieve the desired result.' Since that early ...

US/Canada daily earnings hits & misses May 7 - 1000 ET

Tue, 07 May 2013 14:06:34 GMT

US/Canada daily earnings hits & misses May 7 - 1000 ET
Globe and Mail - May 7, 2013

... INC Q1 BIOTECHNOLOGY USD -0.38 -0.36 0.02 5.0 6.5 1.5 AVIV REIT INC Q1 INVESTMENTS USD -0.36 -0.33 0.03 33.0 34.7 1.7 BIOCRYST PHARMACEUTICALS Q1 BIOTECHNOLOGY USD -0.15 -0.09 0.06 1.3 3.6 2.2 BIOLINE RX LTD Q1 HOME ...

Nova Sees TSMC Order Boost on Smartphone Boom: Israel Overnight

Wed, 01 May 2013 22:31:15 GMT

Nova Sees TSMC Order Boost on Smartphone Boom: Israel Overnight
Businessweek - May 1, 2013

BioLineRX Ltd. (BLRX) slipped 1.1 percent to $1.80 in New York yesterday, the lowest level since April 9. The stock fell for a fourth day, the longest losing streak since March 14.